Food processing environments are prone to microbial contamination, where biofilm formation by persistent bacteria reduces hygiene and food safety. In this study, 27 biofilm-forming bacterial strains were isolated from processing equipment surfaces, with the dominant strains identified as B. cereus LE3, B. cereus YJBR3, and P. cibi F25. An environmental isolate, B. licheniformis YJE5, exhibited no hemolytic activity and demonstrated strong enzymatic potential. Intracellular substances (ICS) extracted from B. licheniformis YJE5, isolated from a food processing environment, significantly inhibited biofilm formation by B. cereus LE3, B. cereus YJBR3, and P. cibi F25 by 47–53% and degraded pre-formed biofilms by 37–44%. Light and confocal laser scanning microscopy confirmed pronounced structural degradation of biofilms following ICS treatment. API ZYM analysis further revealed multiple hydrolytic enzymes, indicating that enzymatic hydrolysis is central to biofilm degradation. Whole-genome sequencing showed a 4.3 Mbp chromosome with diverse metabolic pathways but no antibiotic resistance and virulence genes, confirming the strain’s safety. These findings suggest that B. licheniformis YJE5 represents a safe and eco-friendly candidate for controlling biofilm-associated contamination in food processing facilities.
Human breast milk harbors commensal lactic acid bacteria with probiotic potential, and microbial fermentation may enhance the bioactivity of plant-derived exosome-like nanovesicles (EVs); this study evaluated whether L. plantarum BMSE-HMP251 isolated from breast milk could safely ferment Hordeum vulgare L. and improve the anti-inflammatory activity of derived EVs. BMSE-HMP251 was identified by 16S rRNA sequencing and characterized by biochemical, safety, and genomic analyses. EVs derived from Hordeum vulgare L. extract and BMSE-HMP251-fermented broth were evaluated for physicochemical properties, antioxidant activity, cytotoxicity, and anti-inflammatory activity in LPS-stimulated HT-29 and RAW 264.7 cells. EVs derived from Hordeum vulgare L. fermentation exhibited a distinct size distribution and significantly enhanced bioactivity, including higher DPPH radical scavenging activity and greater suppression of nitric oxide production and proinflammatory cytokine (TNF-α and IL-1β) mRNA expression, compared with EVs from unfermented extracts. These effects were observed following fermentation with the human breast milk-derived strain L. plantarum BMSE-HMP251, which showed species-consistent phenotypic and genomic characteristics and no safety concerns. Overall, fermentation markedly enhances the anti-inflammatory potential of plant-derived EVs, supporting fermentation as a safe and effective strategy to improve their functional value.